Report Detail
Global Antidote Market Insights, Forecast to 2025
- RnM2312815 |
- 04 June, 2019 |
- Global |
- 115 Pages |
- QYResearch |
- Pharma & Healthcare
The use of Antidotes is since the early history of medicine. Antidote is agent that counters the effects of poison or over dosage by another drug. It helps in neutralizing the dangerous effects of a poison in body and has scientific approaches that have been taken to assess the therapeutic value of antidotes. Most important development are related to the role of antidotes in the management of poisoning cases that have incurred in past few years. Various studies for instances, toxicodynamic and toxicokinetic is expected to help in improving the approach taken for the development and evaluation of antidotes. In addition due to increasing global concern for the effectiveness of antidotes has resulted in the exchange of knowledge, scientific information and clinical experience between health care professionals and scientists from different parts of the world. The evolution of antidotal therapy has been characterized with the help of new antidotes such as monoclonal antibodies, also by accurate scientific approach for the effectiveness and the complications that may occur, by novel applications of existing pharmaceuticals, and by increased cooperation and collaboration at global level.
Some key factors such as rising awareness and studies that are conducted for development in identifying toxins in venom bites that by government and companies for better knowledge of these drugs and antidotes is likely to drive the growth of antidote market over forecast period. Identification of snakes is highly important so as to know whether it is snake- specific anti-venoms which are less hazardous as compared to polyvalent anti-venoms. However antidote market has some restraints such as low product of anti-venoms due to rising prices of anti-venoms repressed demand resulting the treatment has declined significantly or even disappeared in some areas is expected to hinder the growth of the antidote market.
The global Antidote market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Antidote market based on company, product type, end user and key regions.
This report studies the global market size of Antidote in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Antidote in these regions.
This research report categorizes the global Antidote market by top players/brands, region, type and end user. This report also studies the global Antidote market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Boehringer Ingelheim Pharmaceuticals
AstraZeneca
Novartis International
Eli Lilly
Portola
Pfizer
Bristol-Myers Squibb
Bayer
Market size by Product
Chemical Antidotes
Physical Antidotes
Pharmacological Antidotes
Market size by End User
Animal Bites
Heavy Metal Poisoning
Others
Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
The study objectives of this report are:
To study and analyze the global Antidote market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Antidote market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Antidote companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Antidote submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
In this study, the years considered to estimate the market size of Antidote are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
This report includes the estimation of market size for value (million US$) and volume (K MT). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Antidote market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Study Coverage
- 1.1 Antidote Product
- 1.2 Market Segments
- 1.3 Key Manufacturers Covered
- 1.4 Market by Type
- 1.4.1 Global Antidote Market Size Growth Rate by Product
- 1.4.2 Chemical Antidotes
- 1.4.3 Physical Antidotes
- 1.4.4 Pharmacological Antidotes
- 1.5 Market by End User
- 1.5.1 Global Antidote Market Size Growth Rate by End User
- 1.5.2 Animal Bites
- 1.5.3 Heavy Metal Poisoning
- 1.5.4 Others
- 1.6 Study Objectives
- 1.7 Years Considered
2 Executive Summary
- 2.1 Global Antidote Market Size
- 2.1.1 Global Antidote Revenue 2014-2025
- 2.1.2 Global Antidote Sales 2014-2025
- 2.2 Antidote Growth Rate by Regions
- 2.2.1 Global Antidote Sales by Regions
- 2.2.2 Global Antidote Revenue by Regions
3 Breakdown Data by Manufacturers
- 3.1 Antidote Sales by Manufacturers
- 3.1.1 Antidote Sales by Manufacturers
- 3.1.2 Antidote Sales Market Share by Manufacturers
- 3.1.3 Global Antidote Market Concentration Ratio (CR5 and HHI)
- 3.2 Antidote Revenue by Manufacturers
- 3.2.1 Antidote Revenue by Manufacturers (2014-2019)
- 3.2.2 Antidote Revenue Share by Manufacturers (2014-2019)
- 3.3 Antidote Price by Manufacturers
- 3.4 Antidote Manufacturing Base Distribution, Product Types
- 3.4.1 Antidote Manufacturers Manufacturing Base Distribution, Headquarters
- 3.4.2 Manufacturers Antidote Product Type
- 3.4.3 Date of International Manufacturers Enter into Antidote Market
- 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
- 4.1 Global Antidote Sales by Product
- 4.2 Global Antidote Revenue by Product
- 4.3 Antidote Price by Product
5 Breakdown Data by End User
- 5.1 Overview
- 5.2 Global Antidote Breakdown Data by End User
6 North America
- 6.1 North America Antidote by Countries
- 6.1.1 North America Antidote Sales by Countries
- 6.1.2 North America Antidote Revenue by Countries
- 6.1.3 United States
- 6.1.4 Canada
- 6.1.5 Mexico
- 6.2 North America Antidote by Product
- 6.3 North America Antidote by End User
7 Europe
- 7.1 Europe Antidote by Countries
- 7.1.1 Europe Antidote Sales by Countries
- 7.1.2 Europe Antidote Revenue by Countries
- 7.1.3 Germany
- 7.1.4 France
- 7.1.5 UK
- 7.1.6 Italy
- 7.1.7 Russia
- 7.2 Europe Antidote by Product
- 7.3 Europe Antidote by End User
8 Asia Pacific
- 8.1 Asia Pacific Antidote by Countries
- 8.1.1 Asia Pacific Antidote Sales by Countries
- 8.1.2 Asia Pacific Antidote Revenue by Countries
- 8.1.3 China
- 8.1.4 Japan
- 8.1.5 Korea
- 8.1.6 India
- 8.1.7 Australia
- 8.1.8 Indonesia
- 8.1.9 Malaysia
- 8.1.10 Philippines
- 8.1.11 Thailand
- 8.1.12 Vietnam
- 8.1.13 Singapore
- 8.2 Asia Pacific Antidote by Product
- 8.3 Asia Pacific Antidote by End User
9 Central & South America
- 9.1 Central & South America Antidote by Countries
- 9.1.1 Central & South America Antidote Sales by Countries
- 9.1.2 Central & South America Antidote Revenue by Countries
- 9.1.3 Brazil
- 9.2 Central & South America Antidote by Product
- 9.3 Central & South America Antidote by End User
10 Middle East and Africa
- 10.1 Middle East and Africa Antidote by Countries
- 10.1.1 Middle East and Africa Antidote Sales by Countries
- 10.1.2 Middle East and Africa Antidote Revenue by Countries
- 10.1.3 GCC Countries
- 10.1.4 Turkey
- 10.1.5 Egypt
- 10.1.6 South Africa
- 10.2 Middle East and Africa Antidote by Product
- 10.3 Middle East and Africa Antidote by End User
11 Company Profiles
- 11.1 Boehringer Ingelheim Pharmaceuticals
- 11.1.1 Boehringer Ingelheim Pharmaceuticals Company Details
- 11.1.2 Company Business Overview
- 11.1.3 Boehringer Ingelheim Pharmaceuticals Antidote Sales, Revenue and Gross Margin (2014-2019)
- 11.1.4 Boehringer Ingelheim Pharmaceuticals Antidote Products Offered
- 11.1.5 Boehringer Ingelheim Pharmaceuticals Recent Development
- 11.2 AstraZeneca
- 11.2.1 AstraZeneca Company Details
- 11.2.2 Company Business Overview
- 11.2.3 AstraZeneca Antidote Sales, Revenue and Gross Margin (2014-2019)
- 11.2.4 AstraZeneca Antidote Products Offered
- 11.2.5 AstraZeneca Recent Development
- 11.3 Novartis International
- 11.3.1 Novartis International Company Details
- 11.3.2 Company Business Overview
- 11.3.3 Novartis International Antidote Sales, Revenue and Gross Margin (2014-2019)
- 11.3.4 Novartis International Antidote Products Offered
- 11.3.5 Novartis International Recent Development
- 11.4 Eli Lilly
- 11.4.1 Eli Lilly Company Details
- 11.4.2 Company Business Overview
- 11.4.3 Eli Lilly Antidote Sales, Revenue and Gross Margin (2014-2019)
- 11.4.4 Eli Lilly Antidote Products Offered
- 11.4.5 Eli Lilly Recent Development
- 11.5 Portola
- 11.5.1 Portola Company Details
- 11.5.2 Company Business Overview
- 11.5.3 Portola Antidote Sales, Revenue and Gross Margin (2014-2019)
- 11.5.4 Portola Antidote Products Offered
- 11.5.5 Portola Recent Development
- 11.6 Pfizer
- 11.6.1 Pfizer Company Details
- 11.6.2 Company Business Overview
- 11.6.3 Pfizer Antidote Sales, Revenue and Gross Margin (2014-2019)
- 11.6.4 Pfizer Antidote Products Offered
- 11.6.5 Pfizer Recent Development
- 11.7 Bristol-Myers Squibb
- 11.7.1 Bristol-Myers Squibb Company Details
- 11.7.2 Company Business Overview
- 11.7.3 Bristol-Myers Squibb Antidote Sales, Revenue and Gross Margin (2014-2019)
- 11.7.4 Bristol-Myers Squibb Antidote Products Offered
- 11.7.5 Bristol-Myers Squibb Recent Development
- 11.8 Bayer
- 11.8.1 Bayer Company Details
- 11.8.2 Company Business Overview
- 11.8.3 Bayer Antidote Sales, Revenue and Gross Margin (2014-2019)
- 11.8.4 Bayer Antidote Products Offered
- 11.8.5 Bayer Recent Development
12 Future Forecast
- 12.1 Antidote Market Forecast by Regions
- 12.1.1 Global Antidote Sales Forecast by Regions 2019-2025
- 12.1.2 Global Antidote Revenue Forecast by Regions 2019-2025
- 12.2 Antidote Market Forecast by Product
- 12.2.1 Global Antidote Sales Forecast by Product 2019-2025
- 12.2.2 Global Antidote Revenue Forecast by Product 2019-2025
- 12.3 Antidote Market Forecast by End User
- 12.4 North America Antidote Forecast
- 12.5 Europe Antidote Forecast
- 12.6 Asia Pacific Antidote Forecast
- 12.7 Central & South America Antidote Forecast
- 12.8 Middle East and Africa Antidote Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
- 13.1 Market Opportunities and Drivers
- 13.2 Market Challenges
- 13.3 Market Risks/Restraints
- 13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
- 14.1 Value Chain Analysis
- 14.2 Antidote Customers
- 14.3 Sales Channels Analysis
- 14.3.1 Sales Channels
- 14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
- 16.1 Research Methodology
- 16.1.1 Methodology/Research Approach
- 16.1.2 Data Source
- 16.2 Author Details
Summary:
Get latest Market Research Reports on Antidote . Industry analysis & Market Report on Antidote is a syndicated market report, published as Global Antidote Market Insights, Forecast to 2025. It is complete Research Study and Industry Analysis of Antidote market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
